Fundz

ForCast Orthopedics raised Series A funding led by OrthoInnovations LLC. The financing will support the development of targeted antibiotic therapies for periprosthetic joint infection.

PRIVATEAug 05, 2025

Round Type

Series A

DenverBiotechnologyHealth CareTherapeutics

Investors

OrthoInnovations LLC

Description

ForCast Orthopedics, a Denver-based company, held the initial closing of a Series A equity financing round. Led by OrthoInnovations LLC, Dr. Charles A. DeCook has joined the Board of Directors as Chief Innovation Officer

Quick answer

ForCast Orthopedics raised an undisclosed amount in a Series A round, dated August 5, 2025. Investors: OrthoInnovations LLC. ForCast Orthopedics is based in Denver, Colorado, United States.

How much did ForCast Orthopedics raise?
ForCast Orthopedics raised an undisclosed amount in a Series A round on August 5, 2025.
Who invested in ForCast Orthopedics?
OrthoInnovations LLC is named as investors in this round.
What does ForCast Orthopedics do?
ForCast Orthopedics is a development-stage company focused on advancing the treatment of periprosthetic joint infection (PJI) with targeted antibiotic therapy.
Where is ForCast Orthopedics based and how big is it?
ForCast Orthopedics is based in Denver, Colorado, United States. Fundz records about 3 employees.
Who are the decision-makers at ForCast Orthopedics?
Fundz holds 1 contact at ForCast Orthopedics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as ForCast Orthopedics that raised within 45 days of this round, from Fundz verified event records.

  • Revive Therapeutics raised $91K (Post-IPO Equity) on September 19, 2025.
  • ARTHEx Biotech raised $87M (Series B) on September 17, 2025.
  • Alchemab Therapeutics raised an undisclosed amount (Series A) on September 9, 2025.
  • iRegene Therapeutics raised an undisclosed amount (Series B) on September 9, 2025.
  • NRG Therapeutics raised $67M (Funding Round) on September 8, 2025.
  • Integra Therapeutics raised $13M (Funding Round) on September 8, 2025.

Who to call at ForCast Orthopedics, and when

A new round usually means ForCast Orthopedics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ForCast Orthopedics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ForCast Orthopedics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ForCast Orthopedics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ForCast Orthopedics

Location

Denver, Colorado, United States

About

ForCast Orthopedics is a development-stage company focused on advancing the treatment of periprosthetic joint infection (PJI) with targeted antibiotic therapy. They are developing a portfolio of targeted antibiotic therapies delivered directly into the infected joint using proprietary technology. The company is led by Peter Noymer, PhD, and Jared Foran, MD. ForCast aims to improve outcomes for patients suffering from PJI.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ForCast Orthopedics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ForCast Orthopedics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

ForCast Orthopedics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.